Tender Details

Country: USA
Summary: Notice of Intent to Award - Blanket Purchase Agreement (Bpa) for Compounded Pharmaceuticals Via 503B Compounding Pharmacies
UST Ref No: 98934995
Deadline: 18 Mar 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: ISS-GSU-24-0008
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
Notice of Intent to Award -Blanket Purchase Agreement for Compounded Pharmaceuticals via 503B Compounding Pharmacies
In accordance with FAR 13.303-2(c)(2), the Navajo Area Indian Health Service, Gallup Service Unit in Gallup, New Mexico, intends to award a Blanket Purchase Agreement (BPA) to Fagron Compounding Services LLC for compounded pharmaceuticals from a FDA-designated 503B facility on an as-needed basis. Items include Phenylephrine 100mcg/ml, Succinylcholine 20mg/10ml, LET 5ml syringe, Oxytoxin 30 units in 500ml (sterile to sterile and API), Epinephrine 8mg per 250ml bag (or other strengths/volumes of the same medications in IV bags as available and required on an as-needed basis). Products must be sterilely compounded in an FDA approved facility with a beyond use date of at least 30 days from manufacture.

The anticipated period of performance is 4/1/2024-3/31/2025. The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 325412- Pharmaceutical Preparation Manufacturing with a small business size standard of 1,300 employees.

No further awards will be made unless the need for Gallup Indian Medical Center changes. The prospective BPA as identified in this notice is sufficient at this time. Any other sources that believe they are capable of fulfilling the government requirements as described are encouraged to submit their capability statement, price lists, and catalogs to the Point of Contact listed below via email only and no later than 3/18/2024 at 10:00 AM (MDT).

In the event additional BPAs are deemed to be in the best interest of the government, capable vendors may be contacted. This notice of intent is not a request for quotations and a solicitation will not be issued in conjunction with the notice of intent.
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Notice of Intent to Award - Blanket Purchase Agreement (Bpa) for Compounded Pharmaceuticals Via 503B Compounding Pharmacies - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Notice of Intent to Award - Blanket Purchase Agreement (Bpa) for Compounded Pharmaceuticals Via 503B Compounding Pharmacies. This tender is published on USARFP under UST Ref No: 98934995 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-03-18.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.